DCGI allowed emergency use of this medicine of Zydus Cadila for the treatment of Corona


Posted on 23rd Apr 2021 06:50 pm by rohit kumar

Corona's uncontrollable pace has created a serious crisis in the country. All the efforts taken by the government are inadequate and the patients of Corona are continuously dying. Meanwhile, the Drugs Controller General of India (DCGI) has approved the emergency use of 'Virafin' of Ahmedabad-based drugmaker Zydus Cadila.

 

 

Zydus Cadila stated that Pegylated Interferon alpha-2b, 'Virafin' is greatly helped by emergency use in adults with Covid-19 infection. Zydus Cadila said that 'Virafin' will be provided to hospitals.

 

 

Earlier, Zydus Cadila had sought approval from the Drug Controller General of India for the treatment of Covid-19. The company had said that the drug Pegylated Interferon Alpha 2b or PegiHep has proved to be effective 91.15 percent. The initial third-phase human trial yielded promising results from the drug. Interim results indicated that timely delivery of the drug may help patients recover more quickly and avoid the complication seen in the advanced stages of the disease.

 

 

Pegylated Interferon Alpha 2b or PegiHep is an approved drug in India and has been re-formulated for the treatment of Covid-19. Preliminary results of Phase III human testing showed that drug use cured 91.15 percent of Covid-19 patients within 7 days and their positive corona test report was negative in the RT-PCR test.

 

 

The company claims that Pegylated Interferon Alpha 2b or PegiHep is a single-dose drug. With single-dose medicine, treatment will be less cumbersome and more economical for the patients. According to the company, during the test, drug-dependent patients also had less need for oxygen support. This makes it clear that the drug can control shortness of breath, which is a major challenge in the treatment of Covid-19.

 

 

"We are excited by the results of the Phase III trial of Pegylated Interferon Alpha 2b which confirmed the possibility of reducing the impact of the virus on the timely use of the disease," said Shravil Patel of Cadila Healthcare. In December 2020, the company was permitted the drug regulator to start Phase III human trials on Covid-19 patients.

2 Like 0 Dislike
Previous news Next news
Other news

LIVE streaming of hearing in Supreme Court for the first time: Beginning with the Uddhav-Shinde case, Constitution Bench said- We want to resolve the dispute soon

Tuesday is a historic day for the Supreme Court. From today people will be able to watch live str

Flood-like situation in many states of the country due to continuous rain, The Meteorological Department has issued a warning of heavy rain; and chaos in hilly areas.

Life has been disrupted in many places due to the rain after the monsoon reached the entire count

Budget 2026-27: PM Modi to hold 'pre-budget' meeting with economists, focusing on tariffs and global challenges.

Prime Minister Narendra Modi will hold a high-level meeting with prominent economists and experts

Atal Setu: 'What is happening on Atal Setu...', people angry over construction of picnic spot just a day after inauguration

PM Modi inaugurated Atal Setu in Mumbai on January 12. Located in Navi Mumbai, it is the longest

Donald Trump got a death threat, a person wrote- 'Just one bullet is needed'; Police took strict action.

A person had threatened to kill US President Donald Trump. Now Shannon Atkins of Florida has been

Russia-Ukraine war: 353 Ukrainian children killed so far, Ukraine kills 38,300 Russian soldiers

The war between Russia and Ukraine, which started on February 24, has been going on for 5 months,

JEE Main Exam 2025: This is a big change in the pattern of the JEE Main exam! know full details

The National Testing Agency (NTA) has made changes in the pattern of the question paper of JEE Ma

TMC vs Centre: 'Over ₹1,290 crore released to Bengal for flood management', Centre responds to Mamata Banerjee's allegation

The central government on Tuesday rejected West Bengal Chief Minister Mamata Banerjee's allegatio

BCCI responsible for the defeat, not Team India: In the last 1 year, our players played 120 matches + 76 days of IPL, tired of both body and mind.

Team India has got only defeat in the T20 World Cup so far. Both Pakistan and New Zealand gave bi

CBSE instructions: If you miss both the term exams, you will not be able to give the compartment exam, know the rules

CBSE has released the guidelines regarding compartment exam eligibility and results for the stude

Sign up to write
Sign up now if you have flare of writing..
Login   |   Register
Follow Us
Indyaspeak @ Facebook Indyaspeak @ Twitter Indyaspeak @ Pinterest RSS



Play Free Quiz and Win Cash